Acadia Healthcare (NASDAQ:ACHC) Rating Lowered to Sell at StockNews.com

Acadia Healthcare (NASDAQ:ACHC) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Monday.

Several other equities research analysts also recently commented on the company. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price objective for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Royal Bank of Canada decreased their price objective on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday, November 18th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday, December 10th. KeyCorp began coverage on Acadia Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. Finally, Barclays lowered their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $73.38.

Acadia Healthcare Trading Up 1.2 %

Shares of Acadia Healthcare stock traded up $0.53 during trading on Monday, hitting $44.85. The company’s stock had a trading volume of 3,484,631 shares, compared to its average volume of 2,339,944. The stock has a market cap of $4.17 billion, a price-to-earnings ratio of 14.70, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77. The stock has a 50-day moving average price of $40.70 and a two-hundred day moving average price of $58.54.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same period last year, the company earned $0.91 earnings per share. The firm’s revenue was up 8.7% compared to the same quarter last year. Equities research analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. GAMMA Investing LLC lifted its stake in Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Acadia Healthcare during the 2nd quarter valued at $59,000. Covestor Ltd lifted its position in shares of Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after buying an additional 1,018 shares during the last quarter. DekaBank Deutsche Girozentrale purchased a new stake in Acadia Healthcare in the 3rd quarter worth about $86,000. Finally, Assetmark Inc. raised its stake in Acadia Healthcare by 66.1% in the 3rd quarter. Assetmark Inc. now owns 1,485 shares of the company’s stock valued at $94,000 after acquiring an additional 591 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.